header logo image


Page 14«..10..13141516..2030..»

Archive for the ‘Molecular Genetics’ Category

Sungeun Kim wins SUNY Oswego Provost’s Award for Scholarly and Creative Activity – NNY360

Sunday, June 14th, 2020

OSWEGO - Dedication to researching complicated neurological disorders and an impressive publication record have earned Sungeun Kim of the electrical and computer engineering faculty the SUNY Oswego Provosts Award for Scholarly and Creative Activity.

Nominator and fellow electrical and computer engineering faculty member Marianne Hromalik noted that, since Kim started at SUNY Oswego in 2016, he has sustained, in addition to his teaching and administrative duties, an impressive record of cutting-edge research.

Kims primary research includes innovative methods for detecting blood-based biomarkers for Alzheimers as well as the integration of the analysis of multiple omics (proteomics, genomics, transcriptomics, etc.) data with neural imaging and clinical data to allow for early detection of Alzheimers and other complex diseases, Hromalik wrote. This work not only represents rapidly expanding research at the very edge of discovery but also has significant medical and social value.

Hromalik praised his track record of peer-reviewed publications -- 93 in all, 21 since joining the Oswego faculty -- as well as his 11 peer-reviewed conference presentations. Kim, who earned his Ph.D. from Purdue Universitys School of Electrical and Computer Engineering, has published two pieces in the prestigious journal Nature, and serves as a peer reviewer for several well-regarded academic journals as well.

Particularly since arrival at Oswego, he has constantly produced outstanding research work demonstrating an extreme productivity in publishing peer-reviewed work and obtaining external funding, wrote ECE faculty member Adrian Ieta. He won three external grants in the area of Alzheimers disease and Parkinsons disease.

Ieta also credited Kim involving Oswego undergraduate students in his research, exposing them to this vital research area, as well as providing instrumental work supporting the college engineering programs earning sought-after ABET accreditation in 2019.

Sungeun is a great colleague, always ready to help, to take up new challenges related to teaching, research or other tasks, Ieta wrote. He has an amazing ability to redefine himself and adjust to objectives and requirements. His teaching performance in introductory and advanced courses is excellent.

Kim has provided additional service to the department and its students by revitalizing ECEs capstone design proposal and capstone design courses and has imparted many of his excellent research techniques to seniors in reorganizing and redesigning their project planning processes, Hromalik said.

Dr. Kims ground breaking research has provided deep understanding of mechanistic insights into the molecular basis of brain disorders and identification of new potential therapeutic targets and diagnostic/biomarker strategies, wrote research colleague Kwangsik Nho of Indiana Universitys Center for Neuroimaging.

He is an excellent researcher and an expert on mechanisms of neurodegenerative disorders such as Alzheimers disease at cellular, molecular and systems levels, Nho added. I have never seen anyone develop complex analytic paradigms and statistical/computational approaches and apply them to highly complex data sets as quickly as Dr. Kim.

I am highly impressed by his research accomplishments at your institution, wrote Li Shen, a professor of informatics and Senior Fellow at the Penn Institute for Biomedical Informatics at the University of Pennsylvania.

He is one of the few people I know that has published consistently in imaging, genetics, computing, neuroscience and disease-specific journals, Shen added. This very clearly demonstrates that he is multidisciplinary. This is a highly desirable trait in a world of modern research and teaching that thrives of the use of multiple disciplines to solve complex problems.

The Provosts Award for Scholarly and Creative Activity is designed as recognition of a significant accomplishment in scholarly or creative activity within ones field of study.

View post:
Sungeun Kim wins SUNY Oswego Provost's Award for Scholarly and Creative Activity - NNY360

Read More...

Renaissance Academy Class of 2020 graduates with over $17 million in scholarships – Montgomery Newspapers

Saturday, June 13th, 2020

PHOENIXVILLE -- On Wednesday, June 10th, 2020, seventy-three seniors graduated from the Renaissance Academy Charter School (RA). The ceremony was held at 7:00 pm and included all the RA traditional Commencement Ceremony through video. The event featured Keynote Speaker and Valedictorian speeches, various awards and scholarships presentations, as well as, the seniors being announced and recognized for earning their diplomas.

The keynote speaker, selected by student vote, was Kelly Najdawi, the K-12 Curriculum Leader of English Language Arts at RA. Born and raised in Radnor. Mrs. Najdawi graduated Magna Cum Laude from West Chester University in 2008, earning a Bachelor of Science in Education with a Middle School English Language Arts Certification. She began working at RA in 2008.

During her 11-year career at RA, Mrs. Najdawi taught English Language Arts to this graduating class in both their 7th and 8th grade years. As their teacher, she made a special connection with this class and is confident they will go on to make a real difference in the world. This class has always impressed me with their academic drive, personal voice, and understanding, so I felt they were already best prepared to take on their future. I trust them and the decisions they are going to make and expect them to positively change the status quo by using everything Renaissance has instilled in them.

Also speaking at the ceremony was Carolyn (Carly) Higgins, 2020 Valedictorian. As Carly reflected back on her time at RA, she spoke of the challenges her class faced together as a unified group. She went on to stress the importance of self-dependency and having the bravery to pursue ones goals in life even when there are powerful obstacles ahead. We have the ability to make our dreams a reality, but you have to have the courage to trust yourself first. Thats the world that I want to live in and I know you do too.

In the fall, Carly plans to be on the pre-med track with a dual major in biology and molecular genetics. While she has not yet decided on her specific college, Carly has been accepted to the Rochester Institute of Technologys Physicians Assistant Program (BS/MS) 5 year program, the University of Rochesters biological sciences program in molecular genetics, the University of Richmond; the University of Hawaii at Mnoa, and West Chester University of Pennsylvanias biology-cell and molecular program.

The RA 2020 Salutatorian, Jeremy Wenger, who will be attending Olin College of Engineering located in Needham, Massachusetts, gave his speech during a graduation achievement and awards event on Monday night. Jeremy spoke about the unity and accomplishments of his graduating class and their ability to change the world with what they know is true. Now it is our time to shape the world. We just have to be brave enough to do it.

The Renaissance Academy Charter School graduating class of 2020 includes:

Grace Katherine Abendshein (Phoenixville), Jamod O. Adams (Norristown), Mark D. Adams (Royersford), Olivia Elizabeth Andreoni (Eagleville ), Joshua David BarrancoSilva (Phoenixville ), Daniel Eric Barron (Coatesville ), Naomi Michele Bruno (Sanatoga), Gavin Daniel Budniak (West Norriton), Olivia Rose Campbell (Royersford), Giavanna M. Caperila (Phoenixville), Emily Paige Cassidy (Phoenixville), Alyssa N. Cekic (Phoenixville), Brianna Chandler (Norristown), Shaun Maria Chester (Phoenixville), Jahi Peter Clark (Norristown), Gabriel Avery Cole (Pottstown), Geoffrey James Cross Jr. (Pottstown), Emilia Anna Crow (Royersford), Susannah Jeannette Cushmore (Norristown), Cornelius I. Dairo (Norristown), Taylor Lynn Darden (Phoenixville), Gianna Rose Debro (RoyersfordA), Jonathan William DeSanto (Phoenixville), Kayla Nicole Diaz (Norristown), Samuel Miles Dooling (Norristown), Ryan James Dunn (Phoenixville) Olivia Rachel Ferst (Norristown), Nicolette G. Foster (East Norriton), Madison Elizabeth Francis (Pottstown), Avinash Suhas Ganguly (Jeffersonville), Kelly Roberta Garman (Collegeville), Morgan Elizabeth Gidney (Gilbertsville), Jaeshon Goodman-Rhodes (Norristown), Grace Riley Grenier (Jeffersonville), Kathryn Ann Guevin (Phoenixville), Shay S. Gustafson (Collegeville), Kiley Rae Henderson (Pottstown), Carolyn S. Higgins (Morgantown, PA), Kaitlin Bryn Irby (Phoenixville), Majesty Sanai Jerry (Norristown), Jurnee Ann Jessie (Norristown), Adam Christopher Johnson (Norristown), Micaiah Allen Jones (Norristown), Elisabeth Faith Kerper (Jeffersonville), Theresa Rose Kolter (Phoenixville), Malachy L. Lacy (Jeffersonville), Tyler Anthony Magyar (Pottstown), Grace Elizabeth Moreschi (Audubon) Lindsey Nicole ODonnell (Norristown), Max Victor Olstad (Phoenixville), Angelina Clair Pagano (Pottstown), Dominique Xandria Parrish-Hankins (Norristown), James Joseph Pritz IV (East Norriton), Aliyah Nicole Quill (Phoenixville, PA), Benjamin Ali-Reza Rabizadeh (Exton), Erin Kathleen Robbins (Collegeville), Tyler Steven Robbins (Jeffersonville), Trevor Mitchell Schmidt (East Norriton, PA), Lily Catherine Shaffer (Collegeville), Paige Kimberly Simon (Norristown), Lauren R. Stauch (Phoenixville), Sara Bernadette Stockett (Norristown), Lanasha Sweeper (East Norriton), Nathen Lim Te (Norristown), Devon Lynn Testa (Phoenixville), Sarah Irene Trexler (Spring City, PA), Nissi Jayanth Vinnakota (Norristown), Dominique Meghan Vinson (Conshohocken), Alexander Joseph Waskiewicz (Norristown), Cassandra Jean Waskiewicz (Norristown), Jeremy Benjamin Wenger (Royersford), Chandler D. White (Norristown), and Cole Raymond Winters (Phoenixville).

These graduates have been accepted to universities such as Rensselaer Polytechnic Institute, Dickinson College, Boston University, Bucknell University, University of Rochester, Ohio State University, Olin College of Engineering, University of Michigan, American University, George Washington University, and Swarthmore College. They have been collectively offered (to date) a scholarship total of $17,101,514.00, a new Renaissance Academy merit scholarship school record. Tracey Behrens OBrien, RA Academic and College Counselor noted that nearly all of the scholarships have been awarded to the students by the individual universities, not from scholarship search sites. It is so exciting to see an unprecedented number of students in the Class of 2020 being recognized by prestigious colleges.

Due to the current COVID-19 conditions, some of the traditional RA end-of-year senior events were held a little differently. The graduates were celebrated over five unique nights. Each night, a different link was released on the Senior Knights 2020 website. The nights had videos and live feeds with different focuses including a night for athletics and the arts; a senior class photo slideshow night; awards and the Salutatorian speech; the senior parent reveal night; the 2020 commencement ceremony; and finally, the graduates processional parade.

About this group of graduates, Upper School Principal, Michelle Boyd said, The Class of 2020 will always stand out for all that they have gone through and how they have persevered through such challenging times. The Class of 2020 displays true grit and determination--they will surely go on to change the world for the better!

The Renaissance Academy staff and Board of Trustees are so very proud of these students and wish them the very best in their future endeavors

Established in 1999, Renaissance Academy is a fully accredited K-12, award-winning, tuition-free, college prep charter school located in Phoenixville, PA. The academy is listed as one of US News & World Reports 2020 Best High School in America. For more information on the school, please visit http://www.rak12.org.The graduation video can also be viewed:RA 2020 Commencement Video (YouTube)

Read more:
Renaissance Academy Class of 2020 graduates with over $17 million in scholarships - Montgomery Newspapers

Read More...

UCD professor asked to resign from EU committee over Covid-19 claims – The Irish Times

Saturday, June 13th, 2020

A University College Dublin (UCD) professor, who chairs the Eurosceptic Irish Freedom Party, has been asked to resign from a leading European Union scientific committee over online claims she made about the Covid-19 pandemic.

In an hour-long interview with a popular alt-right activist on May 10th, which has been viewed hundreds of thousands of times, Prof Dolores Cahill promised to debunk the narrative of the pandemic.

Lockdown and social distancing is not needed to stop the spread of the virus, she said. People who recover are then immune for life after 10 days and deaths and illnesses could have been prevented by extra vitamins, she claimed.

People with underlying health conditions, such as cystic fibrosis, could freely engage in society during the pandemic after spending a few weeks building up their immunity in this manner, she went on.

Opposing vaccinations, Ms Cahill said politicians and the media are using Covid-19 as a fear-mongering propaganda tool to try and take away rights from people and to make them more sick and to force vaccinations on us.

However, the European Commission said the claims made by Ms Cahill, a professor of translational medicine in UCD, could cause significant harm, if taken literally.

Following this, Ms Cahill was asked to resign as vice chair of the Scientific Committee of the Innovative Medicines Initiative (IMI), a partnership between the European Commission and the drugs industry to promote new drugs.

Professor Cahill has been requested by the Chair of the Scientific Council of IMI and the Executive Director of IMI to step down from her function, the commission told The Irish Times.

While as a private person, Professor Cahill is entitled to express her points of view, these are not compatible with the scientific foundations of the Innovative Medicines Initiative, said a Commission spokesperson.

Ms Cahills claims have also caused Berlins Max Planck Institute for Molecular Genetics (MPIMG), where she worked for eight years, to distance itself, saying it did not want to be associated in any way with the claims made.

The IMI echoed these sentiments, saying that they were shocked to see her statements and that her views do not reflect those hold on Covid-19 by of IMI.

A former Max Planck colleague, Prof Hans Lehrach said he was really surprised by Ms Cahills comments: I have no idea why she says things like that, he said.

There is absolutely no proof that people recovering from the disease are immune for life, he said, reflecting the World Health Organisations understanding on the subject.

Vitamins and minerals do help the immune system, but Mr Lehrach said he would very much doubt that they would defend against the virus. The vulnerable would be pretty insane to engage widely during the pandemic.

Ms Cahill also supported the use of hydroxychloroquine to treat Covid-19, one that has been supported, too, by US president Donald Trump. The drug, she said, is safe and effective in treating the disease.

However, Prof Lehrach said that he would be very careful with hydroxychloroquine as testing had proven that it is ineffective as a treatment and has been known to cause death due to heart complications.

The original interview has since been removed by YouTube, but versions can still be found easily online and have clocked up hundreds of thousands of views. Ms Cahill has given a number of similar interviews since.

Ms Cahill is a member of the faculty at UCD school of medicine, where she is the module co-ordinator on a number of subjects, including one taught to first-year medicine students called Science Medicine and Society.

When approached for comment, UCD confirmed that she is part of the universitys faculty, but refused to comment further on her claims, saying only that they are her own views.

Ms Cahill unsuccessfully contested the general election for the Irish Freedom Party in February, eliminated on the second count in Tipperary with a total of 527 votes. She has not replied to requests for comment.

Read this article:
UCD professor asked to resign from EU committee over Covid-19 claims - The Irish Times

Read More...

What to Know About Coronavirus and Air Conditioning, According to Medical Experts – PopCulture.com

Saturday, June 13th, 2020

As confirmed coronavirus cases in several former U.S. hotspots have begun to come down, cases are rising sharply in a number of states, a trend that's expected to with less social distancing protocols in place. Now, as the heat of the summer starts to settle in, there are concerns over how air conditioning could affect exposure.

Manish Butte, Ph.D. and associate professor in the department of microbiology, immunology, and molecular genetics at the University of California, spoke to Health about the matter. They believe that public settings with air conditioning might could be risky. The way air conditioning works is by circulating the air rapidly, removing the humidity. "Less humidity in the air promotes evaporation, which causes droplets in the air to dry up and disappear," Butte explains. So, given that water vapor holds onto heat, when there's less of it in the air, the room cools down.

The droplets themselves are mostly water, but they also can contain any pathogens, which includes coronavirus. A single cough can release about 3,000 droplets and a single sneeze can release up to 30,000 or more. These droplets can vary in size and distance traveled, and when an AC is turned on, airflow from the vent pushes these droplets through the air and potentially into other people. As Butte puts it, "the airflow direction is what matters."

Essentially, since air conditioning is recycled air, it can help the droplets and the contagions therein spread farther. Which, in turn, could result in more infections. Recent studies also suggest that the influx of new coronavirus cases are due directly to the rollbacks of social distancing protocols, which began to lift significantly around Memorial Day. There are currently more than two million cases in the U.S., an unfortunate milestone that has yet to be addressed by the White House.

Despite the spike in cases, U.S. Treasury Secretary Steve Mnuchin asserted in an interview with CNBC that similar actions won't be taken by the government in the future. "We can't shut down the economy again. I think we've learned that if you shut down the economy, you're going to create more damage," Mnuchin said. "And not just economic damage, but there are other areas and we've talked about this: medical problems and everything else that get put on hold."

As of Friday, Johns Hopkins University reports that there have been more than 114,000 deaths from COVID-19 in the U.S. More than 423,000 cases have been reported across the globe.

Go here to read the rest:
What to Know About Coronavirus and Air Conditioning, According to Medical Experts - PopCulture.com

Read More...

No significant change in education budget – The Nation

Saturday, June 13th, 2020

Islamabad - The government on Friday made no significant increase in the development and recurring grants of the Higher Education Commission (HEC) for the fiscal year 2020-2021, freezing the funds allocation above Rs93 billion.

The budget documents said that around Rs64 billion have been proposed as recurring grants while Rs29.47 billion on the development side for the fiscal year 2020-21.

In the fiscal year 2019-20, the government had allocated Rs29.196 billion in the Public Sector Development Program (PSDP). Out of the total allocation of Rs2.47 billion of the proposed funds in development, Rs 1.41 billion is from foreign aid.

The PSDP 2020-2021 said that 29 new projects have been introduced by the HEC while it will continue 47 ongoing projects.

The major new schemes on which above Rs100 million will be spent include Academic Collaboration under CPEC Consortium of Universities (Rs175 million), Development of Infrastructure at Lasbela University of Agriculture, Water and Marine Sciences, Lasbela, Uthal Balochistan (Phase-II) (Rs200million), Development of Main Campus, Bacha Khan University, Charsadda (Rs 166.231 million), Development of University of Buner at Swari (Phase-I) (Rs250 million), Development of University of Sahiwal (Rs300 million), Establishment of 21st Century Water Institute at NED University of Engineering & Technology, Karachi (Rs 470 million), Establishment of an Advanced Molecular Genetics and Genomics Diseases Research and Treatment Centre at Dow University of Health Sciences, Karachi (Rs 352.211 million), Establishment of Four New Departments at Balochistan University of Engineering & Technology (BUET), Khuzdar (Rs200 million), Establishment of National Center of Industrial Biotechnology for Pilot Manufacturing of Bio-products using synthetic Biology and Metabolic Engineering Technologies at PMASARID Agriculture University, Rawalpindi (Rs350miilion), Establishment of New Campus for Govt. College Women University Faisalabad (Rs250 million), Establishment of Sukkar IBA University Campus at Mirpur Khas (Rs170 milion), Establishment of the University of Chitral (Phase-I) (Rs200 million), Livestock Sector Development through Capacity Building, Applied Research and Technology Transfer, University of Veterinary & Animal Sciences (UVAS) (Rs 150 million), Pak-UK Knowledge Gateway- HEC (Rs 158 million), Pilot Project for Data Driven Smart Decision Platform for Increased Agriculture Productivity (Rs 441.300), Provision of Accommodation Facilities for Female Students in Public Sector Universities of Islamabad (Umbrella Project) (Rs 300milion), Provision of missing necessities at King Abdullah Campus, University of Azad Jammu and Kashmir, Muzaffarabad (Rs 100 million), Strengthening & Development of Jinnah Sindh Medical University, Karachi ( Phase-I) (Rs200million), Strengthening and Upgradation of Academic Research and Sports Facilities at Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro (Rs 147million), Strengthening of Center of Excellence in Arts & Design (CEAD), Mehran University of Engineering & Technology (MUET), Jamshoro (Rs100 million), Strengthening of Existing Facilities of Government Sadiq College Women University (GSCWU), Bahawalpur (Rs145million), Strengthening of Infrastructure and Academic Programs of Government College Women University Sialkot (Rs100 million).

View post:
No significant change in education budget - The Nation

Read More...

COVID-19 vaccines: Progress being made, but still a long way to go – Loop News Trinidad and Tobago

Saturday, June 13th, 2020

Multiple companies around the world arepreparing vaccines forimmunisationagainst COVID-19. While researchers are some timeoff from completion, a lot more progress has been made than wasexpected.

Speaking at the Ministry of Healths virtual media conference today,Professor of Molecular Genetics and Virology at the Eric Williams Medical Sciences Centre, Dr Christine Carrington, shed extra light ona fewmain companies which have made significant strides in vaccine development.

Theres a lot in the pipeline, things are progressing at an unprecedented rate but there is still uncertainty and a lot of work to be done. Even if phase three trials identify a safe and effective vaccine that goes into production this year, it is likely to be 12 to 18 months before it would be ready for wide administration, she said.

Dr Carrington says thatin the event ofre-infectionwithout a vaccine, the human body pays specific attention to how it was initially able tofight off the virus so that it can employ similar measures again.

Afteran infection with a given virus, the immune system remembers what it learnt about how to protect the body against that specificvirus so if it encounters that same virus again, it can go into action much more quickly and prevent the infection from taking hold or at least prevent it from causing illnessor from spreading to other people, she explained.

This is what doctors refer to as immunity. Depending on the virus, it can last forever or for a period of months or years.

Vaccines relation to this process is that they contain a component which resembles the virus but will not cause actual infection. This way, if an immune system encountersthe virus, it will already have a reaction prepared due to its familiarity similar to infection and re-infection.

The Professor explained that theres a lot to consider in the decision to employ any specific vaccine; she says its a lengthy process that has to be carefully attended to.

Carrington believes this process is exactly why its important for multiple vaccines to be developed togive populations a better chance at accessing them in a timely fashion.

There is a concerted effort to put certain processes in place to allow rapid dissemination of the vaccine to both developed and developing countries and the pharmaceutical companies involved have committed to doing that at cost during the pandemic period, shesaid.

See original here:
COVID-19 vaccines: Progress being made, but still a long way to go - Loop News Trinidad and Tobago

Read More...

Meet the New Members of the 2020 Malone Scholarship Family | Majic 105.7 – On Air With Ryan Seacrest

Saturday, June 13th, 2020

Meet the New Members of the 2020 Malone Scholarship Family

Jimmy Malone from iHeartMedia Clevelands WMJI had a banner spring with his scholarship program, which was started in 1993.He had 11 students graduate this spring and his goal was to pick 5 or 6 new students, however, MORE were selected.

I was presented me with some truly amazing applicants, said Jimmy Malone.In fact, they did too good of a job because I had an extremely difficult time with the selection process.All of them are very impressive and I am very excited to have 15 new students in my scholarship family.

Whats even more impressive is there is a total of 61 students currently active in the Malone Scholarship Family this year.

Jimmy is very proud of the diverse group of students who receive the 4 year scholarships.There are no restrictions on race, religion, politics etc.The scholarship is available to students who graduate from high schools in Cuyahoga, Lake, Medina, Summit, and Lorain County.

The goal of the Malone Scholarship at College Now Greater Cleveland, a 501(c)(3), is to provide college scholarships to deserving students. To be eligible for the scholarship, students must be Pell Grant eligible, and have a positive outlook on life. Students must also attend a college that is affordable for their financial circumstances.The Malone family looks for students who are committed to graduating on time without excessive debt. Preference is given to students attending a college or university in Ohio.

Jimmys daughter, Angela Malone, and April Malone help him maintain the scholarship and mentor the students.Mentoring is an essential part of the Malone Scholarship program. Our involvement with our students helps them graduate on time, and helps prepare them for life after college.

Congrats to Jimmy and the Class of 2020 on a job well done!

GET MORE INFO OR GET INVOLVED HERE

Go here to see the original:
Meet the New Members of the 2020 Malone Scholarship Family | Majic 105.7 - On Air With Ryan Seacrest

Read More...

Just 10 minutes on the treadmill is enough to change 9,000 molecules in your body, a study found – Insider – INSIDER

Saturday, June 13th, 2020

A 10-minute jog might feel like a cop-out, but a new study by the Stanford University School of Medicine has found that it's enough to alter 9,815 molecules in your body.

There are many existing studies examining the effects exercise has on smaller groups of molecules, but until now no study has committed to the tremendous job of examining how each molecules in the body responds to exercise.

The new study, published in Cell, was small, but it was an ambitious endeavor to document all of the tiny changes to the body's blood that happen post-workout, further highlighting what researchers have known for years: that exercise is crucial for good health.

Researchers still don't know exactly what the impact of each molecular change is, but they do know they are correlated with different bodily functions. Some of the changing molecules were involved in metabolic functions, or digestion or immune system functions, while others were involved in inflammation and insulin resistance levels.

"I had thought, it's only about nine minutes of exercise, how much is going to change? A lot, as it turns out," Snyder told the New York Times.

Crystal Cox/Insider

This intensive, detail-oriented research was only possible because these researchers had been quantifying the molecules of a group of 100 adult men and women. They chose 36 people from their initial pool, including study author Michael Snyder, the chair of the genetics department at Stanford University.

All the participants were between ages 40 and 75, ranging from fit to overweight, and drew blood from them before and after they ran on a treadmill for about 10 minutes.

A majority of the 17,662 molecules they measured (9,815) either increased or declined after the workout. For some people, the molecular changes lingered for longer.

The study was small, and didn't involve participants over 40, and used only a one-time workout, so Snyder and the other researchers can't make any definite conclusions about molecule levels and fitness at this time.

But Snyder is planning more experiments on people's molecule levels, this time with longer workout times and more participants, so he can determine if a simple blood test could be a good way of determining people's physical fitness.

While researching, Snyder and his team discovered thousands of molecules that might correlate with people's fitness levels. Those molecules included markers of metabolism and immunity.

Based off the results of this study, Snyder and his team have created a development test for the idea of using blood tests as fitness markers. In fact, they've already filed a patent application for it.

Visit link:
Just 10 minutes on the treadmill is enough to change 9,000 molecules in your body, a study found - Insider - INSIDER

Read More...

Just 10 minutes on a treadmill can affect your body: Study – The Indian Express

Saturday, June 13th, 2020

By: Lifestyle Desk | New Delhi | Updated: June 13, 2020 10:01:59 am A 10-minute jog or treadmill workout can changes molecules in the body, a study found. (Source: getty images)

A 10-minute workout on a treadmill or a jog is enough to alter more than 9,000 molecules in the body, a new study by the Stanford University School of Medicine found.

Published in the journal Cell, the study aimed to document all the tiny changes that happen to the bodys blood post-workout, highlighting what researchers have been asserting till now, that is, exercise is essential for good health. The study was conducted by Michael Snyder, chair of the genetics department at Stanford University and his team.

I had thought, its only about nine minutes of exercise, how much is going to change? A lot, as it turns out, Snyder was quoted as saying by New York Times.

Some of the changing molecules were involved in metabolic functions or digestive and immune system function while others were involved in inflammation and insulin resistance levels, researchers found.

Read| Post lockdown, how does outdoor fitness change? An expert answers

All participants for the study were between the ages 40 and 75, ranging from fit to overweight. Their blood was drawn before and after they ran on a treadmill for about 10 minutes. A majority of the molecules were found to have either decreased or increased after the workout. For some, the molecular changes lingered for longer.

Researchers found thousands of molecules that might correlate with peoples fitness levels, including markers of metabolism and immunity, reported Insider. They are however yet to know the exact impact of each molecular change.

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Lifestyle News, download Indian Express App.

IE Online Media Services Pvt Ltd

More:
Just 10 minutes on a treadmill can affect your body: Study - The Indian Express

Read More...

Science round-up June 8-13: Brain damage due to Covid-19, natural light in office ensures better sleep, and more – The Indian Express

Saturday, June 13th, 2020

By: Tech Desk | New Delhi | Updated: June 13, 2020 7:14:46 pm Representational Image byenriquelopezgarrefromPixabay.

As part of science round-up, we are curating and bringing you the most important science stories of the week. This way, you do not have to go about fishing for the stories elsewhere. Heres everything that happened from June 8 to June 13, 2020:

A new study, published in the International Journal of Environmental Research and Public Health, found that office workers sleep more hours each night when they are exposed to more sunlight during the day at work. The researchers tested the differences insleep patternsof people working in nearly identical office environments, with the only difference being the amount of lighting they have been exposed to during their shifts.

The researchers found that both groups slept longer when they worked in the office with more natural lighting. On average, they slept 37 minutes longer. The sunlight also had a positive effect on the cognitive tests of the workers, which only grew more and more with each passing day.

In a study, published in the Journal of Alzheimers Disease, scientists have revealed the effects of Covid-19 on the human brain. They conducted a comprehensive review of how the SARS-CoV-2 (novel coronavirus) to classify the damage caused by the virus into three stages.

In the first stage, the damage is limited to epithelial cells of nose and mouth, which leads to transient loss of smell and taste. In the second stage, the overactive immune system causes a cytokine storm in the form of toxic proteins due to the virus. It ends up forming blood clots that cause strokes in the brain.

Also read | Science round-up June 1-7: Sun-Earth like duo found, Gene-editing could destroy coronavirus and more

In the third stage, a much powerful cytokine storm damages the blood-brain barrier, which is basically the protective insulation layer in blood vessels of the brain. It causes the patient to develop seizures, confusion, encephalopathy as the blood content, inflammatory markers, and virus particles invade the brain. It can also send the patient to go into a coma.

This week, the Jupiter, Saturn, and the Moon lined up to form a triangle in the southeastern sky. Dr Ian Musgrave told CGTN that while Jupiter and Venus get close to each other in the sky every year, Jupiter and Saturn only do this once in 20 years.

Research by scientists at the KEM Hospital, Pune, CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and the University of Exeter in the UK, states that a new way of diagnosing type 1 diabetes through genetics could pave the way for better treatment among the Indian population. The research shows that a genetic risk score is effective in diagnosing type 1 diabetes in Indians. Click here to read more.

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Technology News, download Indian Express App.

IE Online Media Services Pvt Ltd

Follow this link:
Science round-up June 8-13: Brain damage due to Covid-19, natural light in office ensures better sleep, and more - The Indian Express

Read More...

A 10-minute workout on the treadmill can change over 9,000 molecules in the body, finds study – MEAWW

Saturday, June 13th, 2020

We know that exercise can work wonders for our bodies. Now, a new study documents its effects, down to our blood. The study found that a 10-minute workout can induce changes in 9,815 molecules. These findings could pave the way for designing blood tests that measure fitness levels.These molecules are involved in various body functions, from metabolism to digestive and immune function. Scientists have long believed that exercise brings changes atmolecular levels, shielding us from heart disease, high blood pressure, type 2 diabetes, cancer and aging.

In this study, scientists from Stanford University studied 36 people between the age of 40 and 75. The participants had varied fitness levels: some were aerobically strong while others were not. Some had diabetes while others had normal sugar levels. Before working out on a treadmill, these volunteers provided blood samples for the study.

The team drew blood immediately after completing the task, and again after a gap of 15, 30 and 60 minutes. In these samples, the team looked for changes in more than 17,000 molecules. Of them, 9,815 either rose or dropped following the physical activity. "I had thought, it's only about nine minutes of exercise, how much is going to change? A lot, as it turns out," Michael Snyder, the chair of the genetics department at Stanford University and senior author of the study told The New York Times.

Snyder compared these changes to an orchestration. For some people, the molecules rose after a workout and then dropped. For others, these changes an increase or decrease stayed for long. They added that the alterations varied depending on an individual's fitness levels. "It was like a symphony. First, you have the brass section coming in, then the strings, then all the sections joining in," he explained.

The study showed that participants struggling with diabetes also displayed differences. Some of these patients often do not respond to insulin, a hormone responsible for keeping blood sugar levels low. After the workout, the team recorded small increases in molecules associated with maintaining healthy blood sugar levels. They also showed a higher increase in molecules involved in responding to an attack, suggesting that they were somewhat resistant to the general, beneficial effects of exercise.

The study has a few limitations, including the fact that the researchers studied only a few participants. Besides, it recorded changes only until an hour after the physical activity. So it does not provide answers to long-term changes to the body. And, it did not involve participants under the age of 40.

In the future, the team hopes to work on experiments that address the gaps left by the current study. They aim to evaluate changes brought about by longer workouts. Comparing resistance exercise and endurance training is also on the cards. In other words, researchers will try to understand which participants are likely to benefit from the two types of workouts. It will also help in designing a fitness blood test, according to the New York Times.The study was published in Cell.

Go here to see the original:
A 10-minute workout on the treadmill can change over 9,000 molecules in the body, finds study - MEAWW

Read More...

Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC – OncLive

Friday, June 12th, 2020

Jean Lopategui, MD, discusses the evolution of targeted therapies in nonsmall cell lung cancer.

Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the evolution of targeted therapies in nonsmall cell lung cancer (NSCLC).

Ten years ago, not many targeted therapies were available in the field, but there has been a tremendous improvement in the treatment of patients with NSCLC, says Lopategui. The 1-year mortality rate of stage IV NSCLC is about 50%. Today, patients who harbor molecular alterations can experience durable remissions due to the development of targeted therapies.

Additionally, checkpoint inhibitors could be a second-line treatment option after disease progression on targeted therapies or chemotherapy. These agents could further extend the lives of patients with NSCLC. Although these agents are not curative, it is encouraging to see the progress that has been made, concludes Lopategui.

Original post:
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC - OncLive

Read More...

Renaissance Academy Class of 2020 Graduates with Over $17 Million in Scholarships – MyChesCo

Friday, June 12th, 2020

PHOENIXVILLE, PA On Wednesday, June 10th, 2020, seventy-three seniors graduated from the Renaissance Academy Charter School (RA). The ceremony was held at 7:00 pm and included all the RA traditional Commencement Ceremony through video. The event featured Keynote Speaker and Valedictorian speeches, various awards and scholarships presentations, as well as, the seniors being announced and recognized for earning their diplomas

The keynote speaker, selected by student vote, was Kelly Najdawi, the K-12 Curriculum Leader of English Language Arts at RA. Born and raised in Radnor, PA, Mrs. Najdawi graduated Magna Cum Laude from West Chester University in 2008, earning a Bachelor of Science in Education with a Middle School English Language Arts Certification. She began working at RA in 2008.

During her eleven-year career at RA, Mrs. Najdawi taught English Language Arts to this graduating class in both their 7th and 8th grade years. As their teacher, she made a special connection with this class and is confident they will go on to make a real difference in the world. This class has always impressed me with their academic drive, personal voice, and understanding, so I felt they were already best prepared to take on their future. I trust them and the decisions they are going to make and expect them to positively change the status quo by using everything Renaissance has instilled in them.

Also speaking at the ceremony was Carolyn (Carly) Higgins, 2020 Valedictorian. As Carly reflected back on her time at RA, she spoke of the challenges her class faced together as a unified group. She went on to stress the importance of self-dependency and having the bravery to pursue life goals even when there are powerful obstacles ahead. We have the ability to make our dreams a reality, but you have to have the courage to trust yourself first. Thats the world that I want to live in and I know you do too.

In the fall, Carly plans to be on the pre-med track with a dual major in biology and molecular genetics. While she has not yet decided on her specific college, Carly has been accepted to the Rochester Institute of Technologys Physicians Assistant Program (BS/MS) 5 year program, the University of Rochesters biological sciences program in molecular genetics, the University of Richmond; the University of Hawaii at Mnoa, and West Chester University of Pennsylvanias biology-cell and molecular program.

The RA 2020 Salutatorian, Jeremy Wenger, who will be attending Olin College of Engineering located in Needham, Massachusetts, gave his speech during a graduation achievement and awards event on Monday night. Jeremy spoke about the accomplishments and unity of his graduating class, as well as their ability to change the world with what they know is true. Now it is our time to shape the world. We just need to be brave enough to do it.

The Renaissance Academy Charter School graduating class of 2020 includes:Grace Katherine Abendshein (Phoenixville, PA), Jamod O. Adams (Norristown, PA), Mark D. Adams (Royersford, PA), Olivia Elizabeth Andreoni (Eagleville, PA), Joshua David BarrancoSilva (Phoenixville, PA), Daniel Eric Barron (Coatesville, PA), Naomi Michele Bruno (Sanatoga, PA), Gavin Daniel Budniak (West Norriton, PA), Olivia Rose Campbell (Royersford, PA), Giavanna M. Caperila (Phoenixville, PA), Emily Paige Cassidy (Phoenixville, PA), Alyssa N. Cekic (Phoenixville, PA), Brianna Chandler (Norristown, PA), Shaun Maria Chester (Phoenixville, PA), Jahi Peter Clark (Norristown, PA), Gabriel Avery Cole (Pottstown, PA), Geoffrey James Cross Jr. (Pottstown, PA), Emilia Anna Crow (Royersford, PA), Susannah Jeannette Cushmore (Norristown, PA), Cornelius I. Dairo (Norristown, PA), Taylor Lynn Darden (Phoenixville, PA), Gianna Rose Debro (Royersford, PA), Jonathan William DeSanto (Phoenixville, PA), Kayla Nicole Diaz (Norristown, PA), Samuel Miles Dooling (Norristown, PA), Ryan James Dunn (Phoenixville, PA) Olivia Rachel Ferst (Norristown, PA), Nicolette G. Foster (East Norriston, PA), Madison Elizabeth Francis (Pottstown, PA), Avinash Suhas Ganguly (Jeffersonville, PA), Kelly Roberta Garman (Collegeville, PA), Morgan Elizabeth Gidney (Gilbertsville, PA), Jaeshon Goodman-Rhodes (Norristown, PA), Grace Riley Grenier (Jeffersonville, PA), Kathryn Ann Guevin (Phoenixville, PA), Shay S. Gustafson (Collegeville, PA), Kiley Rae Henderson (Pottstown, PA), Carolyn S. Higgins (Morgantown, PA), Kaitlin Bryn Irby (Phoenixville, PA), Majesty Sanai Jerry (Norristown, PA), Jurnee Ann Jessie (Norristown, PA), Adam Christopher Johnson (Norristown, PA), Micaiah Allen Jones (Norristown, PA), Elisabeth Faith Kerper (Jeffersonville, PA), Theresa Rose Kolter (Phoenixville, PA), Malachy L. Lacy (Jeffersonville, PA), Tyler Anthony Magyar (Pottstown, PA), Grace Elizabeth Moreschi (Audubon, PA) Lindsey Nicole ODonnell (Norristown, PA), Max Victor Olstad (Phoenixville, PA), Angelina Clair Pagano (Pottstown, PA), Dominique Xandria Parrish-Hankins (Norristown, PA), James Joseph Pritz IV (East Norriston, PA), Aliyah Nicole Quill (Phoenixville, PA), Benjamin Ali-Reza Rabizadeh (Exton, PA), Erin Kathleen Robbins (Collegeville, PA), Tyler Steven Robbins (Jeffersonville, PA), Trevor Mitchell Schmidt (East Norriton, PA), Lily Catherine Shaffer (Collegeville, PA), Paige Kimberly Simon (Norristown, PA), Lauren R. Stauch (Phoenixville, PA), Sara Bernadette Stockett (Norristown, PA), Lanasha Sweeper (East Norriton, PA), Nathen Lim Te (Norristown, PA), Devon Lynn Testa (Phoenixville, PA), Sarah Irene Trexler (Spring City, PA), Nissi Jayanth Vinnakota (Norristown, PA), Dominique Meghan Vinson (Conshohocken, PA), Alexander Joseph Waskiewicz (Norristown, PA), Cassandra Jean Waskiewicz (Norristown, PA), Jeremy Benjamin Wenger (Royersford, PA), Chandler D. White (Norristown, PA), and Cole Raymond Winters (Phoenixville, PA).

These graduates have been accepted to universities such as Rensselaer Polytechnic Institute, Dickinson College, Boston University, Bucknell University, University of Rochester, Ohio State University, Olin College of Engineering, University of Michigan, American University, George Washington University, and Swarthmore College. They have been collectively offered (to date) a scholarship total of $17,101,514.00, a new Renaissance Academy merit scholarship school record. Tracey Behrens OBrien, RA Academic and College Counselor noted that nearly all of the scholarships have been awarded to the students by the individual universities, not from scholarship search sites. It is so exciting to see an unprecedented number of students in the Class of 2020 being recognized by prestigious colleges.

Due to the current COVID-19 conditions, some of the traditional RA end-of-year senior events were held a little differently. The graduates were celebrated over five unique nights. Each night, a different link was released on the Senior Knights 2020 website. The nights had videos and live feeds with different focuses including a night for athletics and the arts; a senior class photo slideshow night; awards and the Salutatorian speech; the senior parent reveal night; the 2020 commencement ceremony; and finally, the graduates processional parade.

About this special group of graduates, Upper School Principal, Michelle Boyd said, The Class of 2020 will always stand out for all that they have gone through and how they have persevered through such challenging times. The Class of 2o20 displays true grit and determinationthey will surely go on to change the world for the better!

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Originally posted here:
Renaissance Academy Class of 2020 Graduates with Over $17 Million in Scholarships - MyChesCo

Read More...

Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases…

Friday, June 12th, 2020

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced a strategic research collaboration with Columbia University Irving Medical Center researchers (Columbia) to advance genetic based therapies for a range of rare neurological conditions, complementary to Ovids current pipeline. This collaboration provides Ovid with the potential to expand its future drug development portfolio and impact individuals living with rare genetic neurological conditions.

Under this research and translational development alliance, Columbia will align its expertise in rare disease genetics and deep clinical understanding of rare neurological diseases with Ovids discovery, translational, and clinical development expertise in neurodevelopmental disorders and rare epilepsies. Ovid will work closely with Wendy K. Chung, M.D., Ph.D., the Chief of Clinical Genetics, and leader of the Precision Medicine Resource in the Irving Institute at Columbia University Irving Medical Center. Dr. Chung is a recognized genetics leader with over 20 years of experience in human genetic research of monogenic and complex traits, mapping and cloning genes in humans, and describing the clinical characteristics and natural history of novel genetic conditions. A 2019 National Organization for Rare Disorders (NORD) Rare Impact Award Honoree, Dr. Chung is also a leader and advocate within the rare disease patient community.

Under the collaboration, Ovid will work together with Columbia scientists to identify molecular targets for developing genetic/molecular therapeutic approaches for rare neurological conditions such as KIF1A-associated neurological disorder (KAND) and other rare conditions.

Ovid has made significant progress in all its late stage clinical programs. We are excited to see multiple read outs of clinical data throughout the year. Its time to begin to build our pipeline for our long-term future in a disciplined and strategic fashion. This next step is built on, and will complement, the important programs we already have in place, said Amit Rakhit, M.D., MBA, President and Chief Medical Officer of Ovid Therapeutics. Joining forces with Columbia and Dr. Chung, a world-class clinical geneticist, will enable Ovid to begin to build a robust gene and molecular therapy platform for the future treatment of inherited neurological conditions.

My laboratory is committed to discovering innovative new targets and therapies to address rare neurological diseases with few or no treatment options, said Dr. Chung. This alliance is further evidence of Columbias unwavering commitment to enabling groundbreaking research and developing cutting-edge technologies to treat neurological conditions. We are excited to partner with Ovid and the patient community to help advance these programs into clinical trials for development of new potential therapies.

About Ovid TherapeuticsOvid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The Companys most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE). For more information on Ovid, please visit http://www.ovidrx.com/.

Forward-Looking Statements This press release includes certain disclosures that contain forward-looking statements, including, without limitation, statements regarding: advancing and commercializing Ovids product candidates, progress, timing, scope and thedevelopment andpotential benefitsofOvids product candidates; and the anticipated reporting schedule of clinical data regarding Ovids product candidates. You can identify forward-looking statements because they contain words such as will,appears,believes and expects. Forward-looking statements are based on Ovids current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements includeuncertainties in the development and regulatory approval processes,andthe fact that initial data from clinical trials may not be indicative, and are not guarantees, of the final results of the clinical trials and are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and/or more patient data become available. Additional risks that could cause actual results to differ materially from those in the forward-looking statements are set forth in Ovids filings with theSecurities and Exchange Commissionunder the caption Risk Factors.Such risks may be amplified by the COVID-19 pandemicand its potential impact on Ovids businessand theglobal economy.Ovid assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Contacts

Investors and Media:Ovid Therapeutics Inc.Investor Relations & Public Relationsirpr@ovidrx.com

Or

Investors: Steve KlassBurns McClellan, Inc.sklass@burnsmc.com (212) 213-0006

Media:Katie Engleman1ABkatie@1abmedia.com(919) 333-7722

Link:
Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases...

Read More...

Outlook on the United States Solid Tumor Testing Industry to 2030 – Analysis and Forecast – GlobeNewswire

Friday, June 12th, 2020

Dublin, June 08, 2020 (GLOBE NEWSWIRE) -- The "U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Biomarker Type, Application, End User, State Region, and Competitive Landscape - Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

According to this market intelligence report titled the U.S. solid tumor testing market was valued at $8,179.7 million in 2019 and is anticipated to grow over $15,396.4 million by 2030. The U.S. solid tumor testing market is expected to grow at a single-digit compound annual growth rate in the forecast period 2020-2030, aided primarily by the high growth in the molecular diagnostics market.

The term solid tumor refers to abnormal cellular growths, which generally comprise sarcomas, carcinomas, and lymphomas. The current solid tumor testing market is mainly dominated by several diagnostic majors, such as Quest Diagnostics Incorporated, Laboratory Corporation of America, Foundation Medicine, which offer a wide variety of testing services for solid tumors. These testing services range from molecular-genetic tests to liquid biopsies for the confirmatory diagnosis of solid tumors. The key players in the product segment include Illumina, Abbott Laboratories, and ThermoFisher Scientific, which offer kits for the analysis of solid tumors.

The solid tumor tests are generally based on technologies such as fluorescence in situ hybridization (FISH), immunohistochemistry (INC), bi-directional sanger sequencing, polymerase chain reaction (PCR), next-generation sequencing (NGS), and other technologies. The underlying utility of diagnostic testing for solid tumors is based on the identification of clinically actionable gene mutations, which provide crucial information on diagnosis, prognosis, and theranosis of solid tumors and thereby facilitate clinical work-up, treatment management, and therapeutic selection.

The existing market of solid tumor testing is favored by multiple factors, which include rising government initiatives, increasing incidence of cancer, thereby increasing the utilization of testing technologies to identify the underlying mutations. In addition, an increasing number of product approvals and launches pertaining to U.S. solid tumor testing market will provide a lucrative growth for this market. Moreover, increasing the use of biomarkers in cancer profiling is also one of the key driving factors for the solid tumor testing market.

Government funding is also one of the major growth factors for the solid tumor testing market because increasing funding by the government is expected to facilitate research institutes and key players to develop as well as market novel assays useful for the diagnosis of several tumors. Increasing funding will lead to the liquidity of the solid tumor market, and thus, companies will develop various testing options for solid tumors to identify the underlying mutations that serve as a possible cause for the disease. All these factors are therefore expected to contribute to the market growth during the forecast period.

Within the research report, the market is segmented on the basis of product type, technology, application, end user, cancer type, biomarker type, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises state-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-degree coverage of the domain.

This report is a meticulous compilation of research on more than 30 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The report also comprises 15 detailed company profiles including several key players, such as Abbott Laboratories, Laboratory Corporation of America, Quest Diagnostics Incorporated, Illumina, F. Hoffmann-La Roche, ARUP Laboratories, Bio-Rad Laboratories, Inc., Asuragen Inc., Cancer Genetics Inc., Invitae Corporation, NeoGenomics Laboratories, Inc., and QIAGEN N.V.

Key trends targeted in the report:

Key Topics Covered:

1 Product Definition1.1 Inclusion and Exclusion

2 Market Scope2.1 Scope of Work2.2 Key Questions Answered in the Report

3 Research Methodology3.1 U.S. Solid Tumors Testing Market: Research Methodology3.2 Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model3.5 Criteria for Company Profiling

4 Market Overview4.1 Definition4.2 Solid Tumor Testing Technologies4.3 Market Size and Growth Potential, $Million, 2019-20304.4 Industry Participants Landscape

5 Epidemiology of Solid Tumors in U.S.

6 Industry Insights6.1 Regulation of Genetic Tests6.1.1 FDA Regulation6.1.2 CMS Regulation6.2 Reimbursement Scenario6.2.1 Impact on Laboratory Industry

7 Market Dynamics7.1 Market Drivers7.1.1 Rising Incidence of Cancers7.1.2 Decreasing Cost of Sequencing7.1.3 Increasing Adoption of Inorganic Growth Strategies in the Market7.1.4 Increasing Research Funding from the National Cancer Institute7.1.5 Expected Increase in Adoption of Genetic Testing7.2 Restraints7.2.1 Reimbursement Cuts in the U.S.7.2.2 Expected Implementation of the Patient Protection and Affordable Care Act in the U.S.7.2.3 High Pricing Pressure7.3 U.S. Market Opportunities7.3.1 Informatics and Technological Innovation for Larger Consumer Base7.3.2 Mushrooming Direct-to-Consumer (DTC) Testing Services Market

8 Competitive Landscape8.1 Key Strategies and Developments8.1.1 Synergistic Activities8.1.2 Approvals8.1.3 Product Launches, Enhancements, and Expansion8.1.4 Acquisitions and Mergers8.2 Product Scenario8.3 Funding Scenario8.4 Market Share Analysis8.5 Growth Share Analysis (Opportunity Mapping)8.5.1 By Company8.5.2 By Technology8.5.3 By Application8.5.4 By Cancer Type

9 U.S. Solid Tumor Testing Market (by Technology)9.1 Overview9.2 Next-Generation Sequencing9.3 In Situ Hybridization9.4 Polymerase Chain Reaction9.5 Immunohistochemistry9.6 Other Technologies

10 U.S. Solid Tumor Testing Market (by Cancer Type)10.1 Overview10.2 Breast Cancer10.3 Prostate Cancer10.4 Colorectal Cancer10.5 Lung Cancer10.6 Melanoma10.7 Endometrial Cancer10.8 Thyroid Cancer10.9 Brain Cancer10.10 Ovarian Cancer10.11 Liver Cancer10.12 Other Cancer Types

11 U.S. Solid Tumor Testing Market (by Type of Biomarker)11.1 Overview11.2 Genetic Biomarkers11.3 Protein Biomarkers11.4 Other Biomarkers

12 U.S. Solid Tumor Testing Market (by Application)12.1 Overview12.2 Clinical12.3 Research

13 U.S. Solid Tumor Testing Market (by End User)13.1 Overview13.2 Hospitals, Diagnostic Laboratories, and Reference Laboratories13.3 Pharmaceutical and Biotechnology Companies13.4 Contract Research Organizations13.5 Academic Research Institutions13.6 Other End Users

14 U.S. Solid Tumor Testing Market (by State Region)14.1 Overview14.2 The South U.S.14.3 The Midwest U.S.14.4 The Mid-Atlantic U.S.14.5 The West U.S.14.6 The Southwest U.S.14.7 New England

15 Company Profiles15.1 Overview15.2 Abbott Laboratories15.2.1 Company Overview15.2.2 Role of Abbott Laboratories in the U.S. Solid Tumor Testing Market15.2.3 Financials15.2.4 Key Insights About Financial Health of the Company15.2.5 SWOT Analysis15.3 Illumina, Inc.15.4 F. Hoffmann-La Roche Ltd.15.5 Bio-Rad Laboratories, Inc.15.6 ASURAGEN, INC.15.7 Cancer Genetics Inc.15.8 QIAGEN N.V.*15.9 Quest Diagnostics Incorporated15.10 ARUP Laboratories15.11 Invivoscribe, Inc.15.12 NeoGenomics Laboratories, Inc.15.13 Invitae Corporation15.14 Opko Health15.15 Laboratory Corporation of America Holdings15.16 OmniSeq15.17 Nanostring Technologies15.18 Guardant Health15.19 Personal Genome Diagnostics15.20 HTG Molecular Diagnostics15.21 Caris Life Sciences15.22 Genomic Testing Cooperative15.23 ArcherDX, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/wer8j9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Continue reading here:
Outlook on the United States Solid Tumor Testing Industry to 2030 - Analysis and Forecast - GlobeNewswire

Read More...

Exercise Alters Molecules In The Blood – Anti Aging News

Friday, June 12th, 2020

According to a recent study published in PubMed a single session of exercise alters 9,815 of the 17,662 different molecules in our blood that were measured in this study, with the types of molecules widely ranging and some being involved in fueling, metabolism, immune responses, tissue repair, or appetite. Within those categories the molecular courses changed within an hour with those that increase inflammation surging early than dropping to be replaced with those more likely to help reduce inflammation.

It was like a symphony, says Michael Snyder, the chair of the genetics department at Stanford University and senior author of the study. First you have the brass section coming in, then the strings, then all the sections joining in.

This study is suggested to be the most comprehensive catalog to date of the molecular changes that occur during and after exercise that highlights how consequential activity/inactivity may be for the human body and health.

Different peoples blood follows different orchestrations; those showing signs of insulin resistance for example tended to show smaller increases in some of the molecules related to healthy blood sugar control and higher increases in molecules involved in inflammation, suggesting that they may be somewhat resistant to the general beneficial effects of exercise. Additionally, depending on the individuals current aerobic fitness levels of other molecules ranged considerably.

Overall the researchers were surprised by their findings regarding what they were observing in the changes in molecular profiles after exercise: I had thought, its only about nine minutes of exercise, how much is going to change? A lot, as it turns out. said Dr. Snyder.

However, this study was not without its limitations such as being a small study that only included participants over the age of 40, and it only looked at a single session of aerobic exercise, as such this study cant tell us anything about the longer term molecular effects of continued training or of how the changes in molecular levels may subsequently alter health.

The research team will be conducting follow up studies with more participants and sustained exercise routines, hoping to establish whether certain molecular responses to exercise may be able to distinguish those who might benefit from emphasizing resistance exercises over endurance training, and whether specific molecular profiles can indicate who has higher/lower aerobic endurance. Such answers may provide information that could allow physicians and researchers alike to check for fitness with a blood sample rather than treadmill stress testing.

See the original post here:
Exercise Alters Molecules In The Blood - Anti Aging News

Read More...

GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET (COVID 19 UPDATE )Overview by Type, Technological Advancements & Forecast to 2027 – Medic…

Friday, June 12th, 2020

The GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET report gives information about the competitive situation among the market vendors and company profile, besides this, the report also provides market price analysis and value chain features. The scope of this industry report includes in-depth insights of global and regional markets with the sense given for variation in the growth of the ABC industry in certain regions. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET research report offers information on production development, market sales, regional trade, investment calculation, investment opportunity, trade outlook, policy, regional market and other important characteristic of the wire and cable market.

A comprehensiveGlobal Point of Care Molecular Diagnostics Marketanalysis report serves to be an ideal solution for better understanding of the market and high business growth. It has become the requisite of this rapidly changing market place to take up such marker report that makes aware about the market conditions around. This market report comprises of an array of factors that have an influence on the market and industry which are industry insight and critical success factors (CSFs), market segmentation and value chain analysis, industry dynamics, drivers, restraints, key opportunities, technology and application outlook, country-level and regional analysis, competitive landscape, company market share analysis and key company profiles.

Market Analysis:

TheGlobal Point of Care Molecular Diagnostics Marketis estimated to rise from the value of USD 627.6 million in 2017 to an estimated value of USD 1933.2 million by 2025, registering a CAGR of 15.1% during the forecast period of 2018-2025. This growth can be attributed to the rising cases of infectious diseases, and the growing demand for approved Point of Care Molecular Diagnostic tests.

Key Market Competitors:Few of the major competitors currently working on the Point of Care Molecular Diagnostics Market are Agilent Technologies Inc., Abbott, F. Hoffmann-La Roche Ltd., Illumina Inc., Hologic Inc., QIAGEN, Myriad Genetics, Cepheid, Genomic Health, GenePOC Inc., DxNA LLC., Binx Health Inc., Spartan Bioscience Inc., Biocartis, Beckman Coulter Inc., Johnson & Johnson Services Inc., Medtronic, Siemens Healthcare GmbH, Grifols S.A., Abaxis, Bayer AG, bioMrieux SA, Bio-Rad Laboratories Inc., Danaher, OraSure Technologies Inc., BD, Sysmex Corporation, Quidel Corporation, and Meridian Bioscience Inc.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-molecular-diagnostics-market

Global Point of Care Molecular Diagnostics Market,By Product (Assays & Kits, Instruments/Analyzers, Services & Software), Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infection, Oncology, Hepatitis, Others), Technology (Polymerase Chain Reaction, In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others), End-User (Physician Offices, Hospitals, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) Industry Trends & Forecast to 2025

Competitive Analysis:

The Global Point of Care Molecular Diagnostics Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Point of Care Molecular Diagnostics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Definition:Global Point of Care Molecular Diagnostics Market

Point of Care Molecular Diagnostics is diagnostic equipment which is used to determine the cause of infectious disease causing agents. These machines/equipments help determine the accurate cause of these diseases in a timely manner, which is of utmost importance when dealing with these kind of diseases and also to implement the correct course of action.

The advancements and developments in the diagnostics market is attributed to the fact that the healthcare industry is focusing on detection and diagnosis in place of pharmaceuticals and medicines, to prevent the development of the diseases. This trend has directly affected the market growth and is helping the market to grow significantly.

North America had the highest revenue share of around 40% of the market.

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-molecular-diagnostics-market

Market Drivers:

Market Restraints:

Segmentation:Global Point of Care Molecular Diagnostics Market

Key Developments in the Market:Global Point of Care Molecular Diagnostics Market

Key Insights in the report:

Market Segmentation:-

To comprehend Global Point of Care Molecular Diagnostics market dynamics in the world mainly, the worldwide Point of Care Molecular Diagnostics market is analyzed across major global regions.

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

For More Insights Get Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-point-of-care-molecular-diagnostics-market

Point of Care Molecular Diagnostics Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Point of Care Molecular Diagnostics report provides the complete structure and fundamental overview of the industry market.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

See the rest here:
GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET (COVID 19 UPDATE )Overview by Type, Technological Advancements & Forecast to 2027 - Medic...

Read More...

Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public…

Friday, June 12th, 2020

BEIJING--(BUSINESS WIRE)-- Genetron Holdings Limited (Genetron Health), a China-based precision oncology company that covers full-cycle cancer care, has entered into a strategic partnership agreement with Thermo Fisher Scientific (Thermo Fisher). With plans to build on the sequencer Genetron S5 (Registration Number 20193220820), the partnership aims to enhance innovation, commercialization and promotion of next-generation sequencing (NGS) platforms in the field of molecular cancer diagnosis in Chinas public hospitals.

The partnership will introduce the Companys medium-throughput NGS system Genetron S5 to public hospitals across China, promoting the application and development of Genetron S5 in more fields, such as reproductive health, genetic disease, pathological microorganism testing, and other independent clinical lab testing and scientific research.

Genetron Health is committed to leading and empowering the cancer diagnostics and treatment industry, said Wang Sizhen, Co-Founder and CEO of Genetron Health. We have been working with Thermo Fisher, one of our world-class partners, to create open, flexible, convenient and accurate molecular diagnostic products, and to offer a comprehensive one-stop solution. Our products and solutions are designed to empower medical institutions continuously improve their diagnostic and treatment capabilities, bringing more accurate and speedy services to the public.

Thermo Fishers memorandum of understanding with Genetron in this field will help further our companies work together to develop IVD solutions for the fast-growing Chinese market, said Tony Acciarito, president of Thermo Fisher Scientific China We look forward to generating significant customer value and promoting precision medicine to improve public health throughout China.

Genetron Health has received National Medical Products Administration (NMPA) approval for clinical application of seven IVD products, which cover three major technology platforms: the NGS, dPCR and qPCR. The NGS platform, in particular, provides flexible combinations of products with low, medium and high-throughput. Genetron Health also offers overall R&D and commercialization solutions for in vitro diagnostic technologies available on multiple technology platforms and in various application scenarios, by fully exploring and tapping into the unique strength of each technology platform.

About Genetron S5

Genetron S5 platform approved by NMPA on November 1, 2019, is a medium-throughput NGS system that enables simple targeted sequencing workflows at an affordable price, without compromising on performance or reliability. Genetron S5 platform offers several throughput options, which provide the flexibility to scale from small to large projects, enabling multiple targeted sequencing applications on a single system. Based on the design, Genetron S5 is particularly suitable for hospitals as it offers more practical solutions and greater scalability.

About Genetron Health

Genetron Health a leading and fast-growing precision oncology company in China that aims to provide one-stop genomic profiling solutions for multiple scenarios covering early screening, diagnosis and monitoring, and biopharmaceutical services. The company collaborates with over 500 hospitals and dozens of biopharmaceutical companies and research institutions, and has developed a large proprietary genomic database.

Genetron Health has established R&D centers in both the United States and China, two manufacturing facilities with both ISO 13485:2016 certification and ISO 9001 2015 certification in China and five clinical laboratories in Beijing (CLIA accreditation and CAP certification), Shanghai, Hangzhou, Chongqing and Guangzhou. The R&D capacities of Genetron Health are supported by a best-in-class research and development team led by scientists at the forefront of cancer genomics research. The company has published many research papers in highly influential worldwide peer-reviewed scientific journals, such as Nature Genetics, Nature Communications, Cell Research and PNAS. For more information, please visit http://www.genetronhealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200610005920/en/

See the original post:
Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China's Public...

Read More...

DNA unlocks the secrets of the Dead Sea Scrolls – Haaretz

Friday, June 12th, 2020

Over 70 years ago, a Bedouin shepherd named Muhammed ed-Dib entered a cave in the Qumran area west of the Dead Sea. In it he found large clay jars containing parchment scrolls wrapped in linen. Ed-Dib didnt know it, but he had stumbled upon the first pieces of one of the most important archaeological discoveries of the 20th century, which would come to be known as the Dead Sea Scrolls. The scrolls opened a window to the spiritual world and quotidian life of the Second Temple period one of the most tempestuous eras in Jewish history and shed light on the process by which various Jewish sects sprang up during that time, one of which would morph into Christianity. But even today these archaeological finds continue to raise more questions than answers.

A major reason for the contentious disputes is that the collection of scrolls in Israel today consists of nearly 25,000 fragments of parchment and papyrus (the lions share of all the known scroll artifacts in the world) which, it is estimated, come from more than 930 different ancient manuscripts. This vast jigsaw puzzle, with an unknown number of pieces that have been lost over time, includes the earliest versions found to date of all the books of the Hebrew Bible (with the exception of the Book of Esther), as well as the biblical apocrypha and many other works previously unknown.

The conventional theory is that some of those works were written or copied by a zealous Jewish sect, identified by most scholars as the Essenes, who led an ascetic life in the desert. However, there is now general agreement that the collection also includes scrolls that originated from outside the sect, written by other learned individuals of that period. Accordingly, the question of which texts are unique to the sect and which were brought in from outside is crucial for understanding the significance of the texts, and to what extent they represent the ideas in currency in Judea of the latter Second Temple period (334 B.C.E.-70 C.E.). A study published this week as the cover story of the scientific journal Cell has harnessed the most advanced tools of biological research in order to help solve the mystery.

The study was conducted by researchers from Tel Aviv University, led by Prof. Oded Rechavi, from the George S. Wise Faculty of Life Sciences and the Sagol School of Neuroscience, and Prof. Noam Mizrahi from the department of biblical studies, in collaboration with Prof. Mattias Jakobsson of Uppsala University in Sweden, the Israel Antiquities Authority, Prof. Dorothee Huchon-Pupko from TAUs zoology department, and Prof. Christopher E. Mason of Weill Cornell Medicine.

Using techniques of DNA sequencing and sophisticated methods of computation, the scientists were able to identify and catalog 26 parchment fragments (plus another 13 leather artifacts) according to the DNA of the animals on whose skins the scrolls were written, and thus to determine which fragments are related to one another, and which ones not.

There are many scrolls fragments that we dont know how to connect, and if we connect wrong pieces together it can change dramatically the interpretation of any scroll, says Prof. Rechavi. Assuming that fragments that come from the same sheep belong to the same scroll, it is like piecing together parts of a puzzle.

The methods the researchers employed have already helped to shed light on a host of important historical and religious issues: how the concept of sacredness in regard to the texts of biblical books changed over time; when basic notions arose in the realm of Jewish mysticism from which the kabbala sprang; and what the origin was of the idea that prayer could replace sacrificial offerings an idea that was formerly thought to have emerged only following the destruction of the Second Temple, in 70 C.E.

But before applying themselves to matters of remote Jewish history, the researchers had first to overcome a series of challenges, starting with how to collect the sensitive samples. In most cases, to avoid damage to the priceless antiquities, the researchers extracted DNA from tiny scroll crumbs (dust) that fell off, or were scraped off the backs of the fragments. The researchers even demonstrated that they could retrieve authentic ancient DNA from adhesive tape used in the 1950s to piece fragments together that was removed from scrolls.

We were not even allowed to touch the scrolls, says Dr. Sarit Anava, from Rechavis laboratory at TAU. The solution, she explains, was for the Israel Antiquities Authority, which stores all of the scroll pieces in its laboratories at the Israel Museum, to place the samples in test tubes, which she took to Sweden to the laboratory of geneticist Mattias Jakobsson at Uppsala University, which was specially adapted to enable the isolation of ancient genetic materials. In this way, a scroll-crumb is transformed into a window onto Jewish history.

Weve thought for years that the scrolls DNA should be examined, says Prof. Jonathan Ben-Dov, an expert on the Dead Sea Scrolls from the University of Haifas department of Jewish history and biblical studies. Everyone waited for it to happen, and it finally succeeded, adds Ben-Dov, who was not involved in the new study.

If so, what has been discovered?

Comparing texts

The first insight divined by the researchers related to the way inhabitants of Judea in the Second Temple period viewed the texts of the Bible. Apparently, the Judaism of that era didnt have one standard version of each of the sacred texts; in other words, not every jot and tittle in the Bible was regarded with the same holiness it would later possess. The scholars reached this conclusion by examining four fragments of parchment containing sections from the Book of Jeremiah.

Today all editions of the Hebrew Bible are absolutely identical, down to the letter. This was the case even before the invention of printing, in fact since the emergence of the authoritative Masoretic Text of the Bible in Tiberias in the early Middle Ages a version that has been preserved almost without alteration to this day. However, other, even-older versions of the Scriptures also exist, notably the Septuagint. This Greek translation of the Hebrew Bible, originating in Alexandria and dating to the third and second centuries B.C.E., was eventually adopted by the Greek Orthodox Church and remains in use today. The differences between the Masoretic Text and the Septuagint are especially striking in Jeremiah.

Its not a matter of the interchange of a letter here and there, or differences between a few isolated words, says Noam Mizrahi, the biblical scholar. The Septuagint text of Jeremiah is 15 percent shorter than the long version reflected in the Masoretic Text. Furthermore, the two texts differ in the way their sections are arranged; in some of the prophecies there are differences in the order and in the content of the verses. The result is, in effect, completely different editions of the prophetic text, and at times entirely different texts.

Differences of this sort in the books of the Hebrew Bible disappeared in the wake of the destruction of the Temple.

What remained are smaller differences at the orthographical level, which persisted into the Middle Ages because the books were copied by hand, Mizrahi continues. In late antiquity and the Middle Ages, rigorous mechanisms of quality control were applied, which ensured that the differences would hardly ever affect an understanding of the content.

Which versions of Jeremiah appear on the scroll fragments examined by the research team? One fragment contains a long version close the Masoretic text, two contain a short version that resembles the Septuagint, and a fourth has a different, independent text.

Mizrahi: There was a scholarly debate over three of these segments, about whether they originally belonged to the same scroll or came from different scrolls, because they look very similar to each other but differ in the handwriting of the copyist.

Enter genetic classification: The scientists discovered that the vast majority of scroll pieces they examined were written on the skin of sheep an animal that could also be bred in the climatic conditions of the Judean Desert 2,000 years ago. The fragments of the Book of Jeremiah that stirred debate, however, were written on the skins of two different animals: two on sheep and two on the skin of a cow, an animal that was not ordinarily raised in the Judean Desert.

For the scientists, discovery of which animal skin was used for copying the texts represents a significant, genetic confirmation of the hypothesis that the writing was not solely the work of the desert sect but of someone from the outside.

Cow-skin scrolls were manifestly not produced there, but originated externally, Mizrahi says. And while theoretically they might have been brought to Qumran as blank parchments, such a scenario makes very little sense from a practical and economic point of view, so it seems they were brought already as written manuscripts. The conclusion that these are two separate versions of Jeremiah neither of which, apparently, was copied by the local sect, but rather originated in a different context and place, points to the possibility that an openness to divergent texts of the Holy Scriptures reflects a more general approach in Judea at that time.

He adds, As long as there was only the Greek translation, it could be argued that [the existence of different versions could be attributed to] the Diaspora [the Jews of Alexandria]. But the scrolls indicate that the multiplicity of versions was a basic feature of Judaism as a whole, during that period, and particularly in Judea.

According to Prof. Michael Segal an expert in the Dead Sea Scrolls and the dean of humanities at the Hebrew University of Jerusalem the new findings are consistent with a current theory that holds that some of the scrolls came from outside Qumran. One reason is that some of them antedate the founding of the community itself, notes Segal, who was not involved in the current study. To which Jonathan Ben-Dov adds, We have been playing with theories about the biblical text for hundreds of years. Now, thanks to biology, we have an Archimedes fulcrum, with whose aid we can examine those theories.

Heavenly temple

One of the greatest challenges of DNA research is to locate genetic material of sufficiently high quality to enable laboratory analysis. According to Prof. Yitzhak Pilpel, head of the molecular genetics department of the Weizmann Institute of Science in Rehovot, who was not involved in the study, this is particularly true in cases of genetic samples that need to be extracted from the most minuscule fragments of ancient relics. To overcome this obstacle, scientists involved in the new research used a variety of methods that enabled them to examine the surviving ancient genetic material at different resolutions. For example, the species of animal from which the scrolls were fashioned sheep or cow was identified by comparing sections of the mitochondrial DNA found in the cells of the parchment skin to that of more than 10 species of animals until a match was found. Other methods allowed the scientists to determine the genetic relationship between the different sheep whose skins were used in creating the scrolls.

The second method analyzing the basic genetic groups (haplogroups) of the sheep made it possible for the researchers to derive insight concerning Songs of the Sabbath Sacrifice, one of the most intriguing and important texts found in the Qumran scrolls.

This is a composition that was unknown before the discovery of the scrolls, but 10 copies of it were found among the scrolls themselves clear evidence of its importance, Prof. Mizrahi explains. What was not clear was whether the importance of Songs of the Sabbath Sacrifice was unique to the sectarian group that left the scrolls behind, or whether it represents the works popularity among a broader community.

One reason for the considerable interest in this composition is that one copy of the Songs was found 55 kilometers south of the Qumran caves, in the excavations on Mt. Masada. Many scholars had discerned a connection between the discoveries at both sites. In their view, during the Great Revolt of 66-70 C.E, when the Romans who ruled the country were preparing to lay siege to Jerusalem, and the Qumran community was annihilated the sects survivors fled and joined the Jewish rebels who had barricaded themselves at Masada.

The new study calls this hypothesis into question, at least as far as the textual evidence is concerned. A comparison of the DNA of the sheep showed that the scrolls found at Qumran were all made from animals belonging to one genetic population group, whereas the scroll found at Masada was made from the skin of a sheep from a different group.

We did not expect that result, Mizrahi admits. It shows that it is unlikely that this copy of the Songs was brought to Masada by a refugee from Qumran, because this scroll differs biologically, materially, from the scrolls found at Qumran.

According to Ben-Dov, the new biological information thats come to light does not rule out a connection between the sites. After all, the study itself showed that at Qumran there were scrolls made from the skin of different animals, such as cows, he says. Still, he adds, the findings reinforce the possibility that the Masada scroll is not directly connected to Qumran. This possibility that this religious work was widely circulated in the Judea at that time, outside the sect has significant implications for understanding the spiritual life of Second Temple Judea.

Mizrahi adds that discovering the source of the copies of Songs of the Sabbath Sacrifice is particularly important, because of the uniqueness of the text. It is a liturgical composition a collection of Sabbath prayers but also contains an internal narrative. It describes the heavenly temple and the angels rite of worship. It can be inferred, then, that the authors and readers of the text assumed that there is in heaven a temple parallel to the earthly one and that angel-priests in it are engaged in worship. However, activity in the heavenly temple did not center around offering sacrifices as was true in the Jerusalem Temple, but focused on nonstop uttering of praises of God.

Why is this important? This was a period when the Temple was still operating, Mizrahi explains. The conventional view of researchers until a generation ago was that the idea of fixed and statutory prayer replacing sacrificial offerings in the Temple emerged in Judaism only after the destruction of the Second Temple. Accordingly, at the dawn of Qumran studies, the approach that derived from analysis of the Dead Sea Scrolls and the discovery of the prayer collections they contain, was that the Judean Desert sect predated Judaisms transition from sacrificial rituals to the practice of prayer. Scholars in the past explained that the disputes between different sects of the Second Temple period sects, and the insistence of one of them on particularly strict rules of ritual purification led to the latter keeping their distance from the Jerusalem Temple and remaining secluded in the desert hence their development of the idea of prayers as a substitute.

However, Mizrahi says now, this hypothesis needs to be reconsidered in light of the discovery that the Masada copy of Songs of the Sabbath Sacrifice is not genetically linked to the Qumran copies.

It turns out that the idea of prayer as the center of worship was popular beyond Qumran. Were these other communities of the [same] sect that lived in other places? Possibly, he says, referring to a theory that offshoots of the main sect were active elsewhere. But now we know that the centrality of prayer in the worship of God was not unique to Qumran.

Beyond this, there are additional distinctive features of the Songs of the Sabbath Sacrifice, among them elements that would surface centuries later in early Jewish mystical writings known as Hekhalot and Merkhavah (literally, the Heavenly Palaces and the Divine Chariot-Throne) literature. This is a collection of mystical compositions of which the earliest manuscripts were found in the Cairo Genizah. Scholars are divided about the dating of the original works, but its conventionally thought that they were written in the second half of the first millennium C.E.

Says Mizrahi: This is the oldest layer of Jewish mystical literature, and the foundation on which other mystical doctrines were built, including what would subsequently feed the kabbala literature.

For example, the concept of the chariot of God, which first appears in Ezekiel, develops in the Songs of the Sabbath Sacrifice and hundreds of years later in the Hekhalot literature into the idea that the believer can, through a spiritual journey, be elevated to the heavenly temple, enter the Holy of Holies and see Gods chariot. For 30 years, scholars have been arguing about the nature of the connection between the Songs of the Sabbath Sacrifice and the mystical literature that appeared later.

Over the years, the discovery of this text and the fact that it was attributed to the Qumran community contributed to cultivating the notion that the sect served as a source of inspiration for ideas that later informed Jewish and Christian mysticism. The problem was that until now, no one knew exactly how the transition came about.

As long as Songs of the Sabbath Sacrifice was perceived as a work unique to Qumran, there was a missing link between Qumran and the whole mystical tradition that develops in late antiquity, the early Middle Ages and afterward, Mizrahi says. But if we know now that Songs of the Sabbath Sacrifice was a work that was known outside Qumran and until now there was no clear sign of that then we can understand that there were other channels of transmission of these texts and ideas that bridge the missing link.

Scroll clusters

Another significant achievement of the new genetic study is to reinforce one of the leading methods today for classifying the Dead Sea Scrolls, which until now was based on an analysis of the way they were written. For this purpose, the scientists analyzed sheep sequence variation in the nuclear genome, by means of deep DNA sequencing and algorithms developed by Moran Neuhof, Dr. Hila Gingold and Or Sagy from Prof. Rechavis laboratory. These comparisons enabled them to distinguish between a cluster of scrolls made from sheep bearing high genetic similarities, and scrolls made from sheep that do not belong to this cluster and that are also genetically remote from one another.

This time the researchers applied DNA analysis to the nuclear sheep genome (rather than the mitochondrial genome, which doesnt allow distinguishing between individual sheep), to evaluate the system of classification proposed by Prof. Emanuel Tov, who was editor-in-chief of the international Dead Sea Scrolls Publication Project. The Bible scholar classified the findings into two groups according to 20 scribal signs, such as how the authors of the scrolls inserted corrections, spelled words, marked the explicit name of God (the Tetragrammaton) and so on. According to this classification method, presented in a series of publications, principally during the 1930s, the overwhelming majority of the texts possessing a content unique to the members of the Qumran sect match one scribal style, which was labeled QSP (Qumran Scribal Practice). According to Tov, these scrolls were written by the sects scribes. Tov believes that the other scrolls found at Qumran, labeled Non-QSP, were probably brought to the sect from the outside.

It turns out that all the scrolls we sampled whose nuclear DNA indicates that they belong to one cluster, namely that they are genetically close, were classified as QSP scrolls, whereas the Non-QSP scrolls belong to different clusters, Rechavi says.

Ben-Dov notes that in recent years the theory about the Qumran scribal practice came in for criticism, but now the researchers have shed new light on the subject. Until now this group of scrolls was characterized according to philological markers, and now we also have biological markers, he says.

In addition, the fact that no genetic similarity was found between the external scrolls and the first cluster nor between any of those scrolls in the external cluster supports the hypothesis that the Non-QSP scrolls originated in various places throughout Judea. One of the copies of Songs of the Sabbath Sacrifice found in Qumran now turns out to belong to the second cluster as well.

This is further reinforcement for the hypothesis that the Songs was widespread outside the sects circles, Rechavi avers.

One of the reasons for the confusion about the connection between different scroll fragments stems from the way they were found. Only about a quarter of the scrolls were found in situ by archaeologists, while most were found by Bedouin and sold to researchers in the 1950s, with the sellers not always having an interest in saying exactly where the valuable antiquities had come from. Now, with the aid of the new genetic tools, the scientists are able to unravel part of the tangle, and identify mistakes of earlier researchers. For example, the study found that a fragment from Isaiah, which until now was cataloged as part of the Qumran scrolls, deviates genetically from all the other Qumran scrolls. This raises intriguing questions: Did the fragment really come from the Qumran caves, or perhaps from a place that hasnt yet been identified? Mizrahi notes, adding, Perhaps segments resembling it are still lurking among the 25,000 scroll fragments found to date.

What next? Pnina Shor, founder of the Dead Sea Scrolls Project unit in the Israel Antiquities Authority, who took part in the research study, notes that the authority is working to enlist state-of-the-art scientific tools in an effort to improve the deciphering and preservation of the scrolls. With the aid of international collaboration, the IAA is now drawing on tools such as artificial intelligence to make progress in assembling the physical and textual jigsaw puzzle. Another plan is to make use of a particle accelerator to read segments of a scroll that congealed, rendering it impossible to separate its layers. The IAA is also adopting the biological tools. The present study is proof of its feasibility, Shor says.

The study examined only a small number of the scrolls, but according to the scientists a promising path to solving the riddles residing in the Qumran scrolls lies in expanding the use of genetic analysis. The development of the methods that made the latest breakthroughs possible took years, but the researchers are convinced that the next stage will be far more rapid. Rechavi: I hope we will be able to sample a large number of scrolls and discover how to put the puzzle together.

According to Prof. Oren Harman, a historian of science from Bar-Ilan University, the use of ancient DNA is like the invention of a new tool, like the microscope or the telescope. It allows us to tell a new story, sometimes a different story from the one the archaeologists, anthropologists and historians told until now. Like every scientific tool, emphasizes Harman, who was not involved in the study, ancient DNA should also serve to solve good questions, and not stand on its own. Its important to remember that analysis of the results of studies that rely on ancient DNA is based on a statistical interpretation of the data, and that different interpretations are possible for the same data.

Prof. Pilpel, the molecular geneticist, notes that the researchers conclusions about the scrolls they examined appear to be solid. One of the reasons for this is the choice of scrolls that are of interest if it is shown that they are not connected to one another. It is easier to establish that two sections of skin do not belong to the same animal all you have to do is show that there are a certain number of differences in the DNA, and that can be done even if the genetic material that remains is of low quality.

The various Bible scholars surveyed by Haaretz all say they are certain that even if the biological information serves only to show that different scroll fragments do not match one another, there are many fascinating questions to ask with the use of this tool. There is hope of achieving a more accurate classification of the scrolls in the future, says Michael Segal. According to Ben-Dov, We [Bible scholars] have been wrestling with different theories for so many years, but biology is providing us with a new way to make our arguments.

Prof. Mizrahi sums up the field of scrolls research in the following way: We are adrift on an ocean of uncertainty, and scientific research creates a small island of probability in it. The more we increase knowledge, the more we discover more cogently how much we have left to discover.

View original post here:
DNA unlocks the secrets of the Dead Sea Scrolls - Haaretz

Read More...

Molecular Genetics Company MiraDx Offers COVID-19 Viral Testing To U.S. Universities and Colleges – Business Wire

Monday, June 1st, 2020

LOS ANGELES--(BUSINESS WIRE)--MiraDx, a Los Angeles-based molecular genetics company that transitioned its CLIA-certified lab to provide COVID-19 tests for essential workers, is now expanding access to its PCR viral testing to public and private universities and colleges across the country. MiraDx aims to enable students, faculty, and staff to resume on-campus education later this year in an environment that provides a clear framework and easy and comprehensive access to highly accurate testing for the COVID-19 virus.

MiraDx is able to develop testing programs customized to the needs of an individual institution. Notably, the MiraDx lab, which is now exclusively processing COVID-19 tests, has dedicated reserved capacity for college programs, both to optimize turnaround time and mitigate the backlog many other labs are currently experiencing. With specific days allocated to individual schools, MiraDx will be able to deliver test results back to school officials through a secure server within 48 hours of receipt at the lab.

Accurate and sensitiveCOVID-19 testing of all Americans is of the utmost importance, said Dr. Joanne Weidhaas, co-founder of MiraDx. As our company continues to provide testing for thousands of first responders and essential workers, we have also turned our attention to another matter of national importance: enabling our youth to continue their on-campus education as safely and as soon as possible. Our goal is to contribute in a meaningful way to institutions of higher learning to allow students, faculty, and staff to return to campus in good health and give parents peace of mind that their children are safe.

MiraDxs discussions with over 100 schools across the country, along with guidance from health officials, have helped to inform the development of emerging testing protocols, to include day one clearance testing of the entire student body and faculty, followed by repeat sentinel testing throughout the semester.

We are focused on delivering the highest quality, most sensitive and dependable testing programs possible, said Dr. Weidhaas, herself an educator at UCLA. We are only going to commit to programs today we know we can achieve in the fall we are not going to sell capacity we do not have, and in fact, we are building in a buffer of capacity in each college testing day.

MiraDx has a CLIA-certified lab with a high complexity molecular processing designation that allows it to conduct PCR testing, a highly sensitive approach that results in over 90 percent accuracy in COVID-19 testing and is considered the gold standard in testing. To determine whether an individual is infected with COVID-19, a sample is collected from a swab of the back of the throat, where the highest viral load exists for this coronavirus. The MiraDx test includes an air-tight vial, collection swab, a biohazard bag, and simple instructions for collecting the sample, which is collected under the supervision of a healthcare professional. MiraDxs analysis technique can identify as little as four copies of COVID-19 RNA in an individual sample, meaning that the virus can be detected even during the early stages of infection and/or in asymptomatic individuals. Non-PCR based testing approaches are either less sensitive (resulting in more false negatives) or do not tell patients when they are no longer contagious, which either leaves them in quarantine too long or presents the risk of them coming out of quarantine too soon.

MiraDxs COVID-19 test has been developed in line with the FDAs Emergency Use Authorization requirements.

About MiraDx

Dr. Joanne Weidhaas, MD, PhD, MSM is the co-founder of MiraDx and a professor and vice-chair in the department of radiation oncology at UCLA.

MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer treatment, and now performs COVID-19 testing. Its goal is to improve human health and advance personalized medicine through the application of novel functional germline biomarkers. To learn more about MiraDx, please visit miradx.com. Please send inquiries to info@miradx.com

Read the original here:
Molecular Genetics Company MiraDx Offers COVID-19 Viral Testing To U.S. Universities and Colleges - Business Wire

Read More...

Page 14«..10..13141516..2030..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick